CVR: 34621942
VAR2 PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The company is owned by ONCOMAL ApS and Københavns Universitet. The company has 11 employees. In 2025, the company reported a gross profit of DKK -21,739,014 and a net result of DKK -19,726,508 compared with DKK -21,006,013 the year before. Equity amounted to DKK 82,032,248.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er - direkte eller via besiddelse af kapitalandele i andre selskabet - at drive virksomhed indenfor kræftbekæmpelse samt anden virksomhed, der efter direktionens skøn er forbundet dermed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -21.7 mio. | -19.7 mio. | 85.7 mio. | 82 mio. | 7 | |
| 2024 | -22.7 mio. | -21 mio. | 66.7 mio. | 64.5 mio. | 8 | |
| 2023 | -22.3 mio. | -19.1 mio. | 59.3 mio. | 48.3 mio. | 6 | |
| 2022 | -6.4 mio. | -6.8 mio. | 70.2 mio. | 67.4 mio. | 5 | |
| 2021 | -4.4 mio. | -5.9 mio. | 38.5 mio. | 37 mio. | 7 | |
| 2020 | -3.4 mio. | -5.4 mio. | 44.8 mio. | 42.9 mio. | 8 | |
| 2019 | -4.7 mio. | -6.9 mio. | 51.1 mio. | 48.3 mio. | 8 | |
| 2018 | -1.9 mio. | -4 mio. | 56.5 mio. | 55.1 mio. | 6 | |
| 2017 | -4 mio. | -4.4 mio. | 14.2 mio. | 13.7 mio. | 3 | |
| 2016 | -1.6 mio. | -1.9 mio. | 10.2 mio. | 9.9 mio. | - | |
| 2015 | -654 t. | -770 t. | 3.6 mio. | 3.5 mio. | - | |
| 2014 | -829 t. | -1 mio. | 1.1 mio. | 906 t. | - | |
| 2013 | 68 t. | 66 t. | 181 t. | 118 t. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
VAR2 PHARMACEUTICALS ApS has published its annual report for 2025. Gross profit came to DKK -21,739,014, and the net result was DKK -19,726,508.
As of June 30, 2025, Tanja Rainer has joined the board of directors of VAR2 PHARMACEUTICALS ApS.
As of June 30, 2025, Silviya Stoykova has joined the board of directors of VAR2 PHARMACEUTICALS ApS.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2024. Gross profit came to DKK -22,697,872, and the net result was DKK -21,006,013.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2023. Gross profit came to DKK -22,299,600, and the net result was DKK -19,118,976.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2022. Gross profit came to DKK -6,358,279, and the net result was DKK -6,805,156.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2021. Gross profit came to DKK -4,433,183, and the net result was DKK -5,904,971.
As of April 1, 2022, Josef Rainer has joined the board of directors of VAR2 PHARMACEUTICALS ApS.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2020. Gross profit came to DKK -3,413,013, and the net result was DKK -5,390,471.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK -4,729,732, and the net result was DKK -6,850,804.
As of March 31, 2020, Ulf Andreas Linderoth Norlin has stepped down as director of VAR2 PHARMACEUTICALS ApS.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2018. Gross profit came to DKK -1,944,893, and the net result was DKK -3,967,644.
As of May 18, 2019, Mai-Britt Zocca has left the board of directors of VAR2 PHARMACEUTICALS ApS.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK -3,957,851, and the net result was DKK -4,379,473.
As of January 18, 2018, Ulf Andreas Linderoth Norlin is registered as director of VAR2 PHARMACEUTICALS ApS.
As of January 18, 2018, Thor Grundtvig Theander has stepped down as director of VAR2 PHARMACEUTICALS ApS.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK -1,632,539, and the net result was DKK -1,856,736.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2015. Gross profit came to DKK -654,287, and the net result was DKK -769,829.
As of May 14, 2016, Mai-Britt Zocca has joined the board of directors of VAR2 PHARMACEUTICALS ApS.
As of May 14, 2016, Thor Grundtvig Theander has joined the board of directors of VAR2 PHARMACEUTICALS ApS.
As of May 14, 2016, Ali El-Salanti has joined the board of directors of VAR2 PHARMACEUTICALS ApS.
As of May 14, 2016, Mads Daugaard has joined the board of directors of VAR2 PHARMACEUTICALS ApS.
As of May 14, 2016, Peter Schröcksnadel has joined the board of directors of VAR2 PHARMACEUTICALS ApS.
As of May 14, 2016, Poul Henrik Bredahl Sørensen has joined the board of directors of VAR2 PHARMACEUTICALS ApS.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2014. Gross profit came to DKK -828,912, and the net result was DKK -1,013,312.
VAR2 PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK 68,068, and the net result was DKK 65,528.
As of November 7, 2013, ONCOMAL ApS is registered as an owner of VAR2 PHARMACEUTICALS ApS with an ownership share of 90%.
VAR2 PHARMACEUTICALS ApS has published its interim report for the period June 1, 2012 – December 31, 2012.
As of June 1, 2012, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of VAR2 PHARMACEUTICALS ApS.
As of June 1, 2012, Thor Grundtvig Theander is registered as director of VAR2 PHARMACEUTICALS ApS.
As of June 1, 2012, Ali El-Salanti is registered as director of VAR2 PHARMACEUTICALS ApS.
As of June 1, 2012, Mads Daugaard is registered as director of VAR2 PHARMACEUTICALS ApS.
As of June 1, 2012, Københavns Universitet is registered as an owner of VAR2 PHARMACEUTICALS ApS with an ownership share of 5%.
VAR2 PHARMACEUTICALS ApS was founded on June 1, 2012.
Companies in the same industry and area
CVR 40766383
CVR 46613139
CVR 34688605
CVR 44504332
CVR 43917897